PAPER Chen X, Huang R, Chen Y, Zheng Z, Chen K, Song W, Zhao B, Yang Y, Yuan L, Shang H
SEARCH RESULTS
329963 RESULTS
PAPER Grossman M, Elman L, McCluskey L, McMillan CT, Boller A, Powers J, Rascovsky K, Hu W, Shaw L, Irwin DJ, Lee VM, Trojanowski JQ
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
JAMA Neurol. 2014 Apr;71(4):442-8. PubMed: 24492862PAPER Romano M, Buratti E, Romano G, Klima R, Del Bel Belluz L, Stuani C, Baralle F, Feiguin F
Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43).
J Biol Chem. 2014 Mar 7;289(10):7121-30. Epub 2014 Feb 3 PubMed: 24492607PAPER Rosini M, Simoni E, Minarini A, Melchiorre C
Multi-target Design Strategies in the Context of Alzheimer's Disease: Acetylcholinesterase Inhibition and NMDA Receptor Antagonism as the Driving Forces.
Neurochem Res. 2014 Feb 4; PubMed: 24493627PAPER Bloom GS
Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
JAMA Neurol. 2014 Apr;71(4):505-8. PubMed: 24493463PAPER Jefferson AL, Gifford KA, Damon S, Chapman GW 4th, Liu D, Sparling J, Dobromyslin V, Salat D, for the Alzheimer’s Disease Neuroimaging Initiative
Gray & white matter tissue contrast differentiates Mild Cognitive Impairment converters from non-converters.
Brain Imaging Behav. 2014 Feb 4; PubMed: 24493370PAPER Young TR, Kirchner A, Wedd AG, Xiao Z
An integrated study of the affinities of the Aβ16 peptide for Cu(I) and Cu(II): implications for the catalytic production of reactive oxygen species.
Metallomics. 2014 Mar;6(3):505-17. Epub 2014 Feb 3 PubMed: 24493126PAPER Pietropaolo S, Feldon J, Yee BK
Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer's disease.
Cogn Affect Behav Neurosci. 2014 Feb 4; PubMed: 24492993PAPER Chang YS, Chen HL, Hsu CY, Tang SH, Liu CK
Parallel improvement of cognitive functions and P300 latency following donepezil treatment in patients with Alzheimer's disease: a case-control study.
J Clin Neurophysiol. 2014 Feb;31(1):81-5. PubMed: 24492450PAPER Conejero-Goldberg C, Gomar JJ, Bobes-Bascaran T, Hyde TM, Kleinman JE, Herman MM, Chen S, Davies P, Goldberg TE
APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms.
Mol Psychiatry. 2014 Feb 4; PubMed: 24492349PAPER Sorrentino P, Iuliano A, Polverino A, Jacini F, Sorrentino G
The dark sides of amyloid in Alzheimer's disease pathogenesis.
FEBS Lett. 2014 Mar 3;588(5):641-52. Epub 2014 Jan 31 PubMed: 24491999PAPER Cedervall Y, Halvorsen K, Aberg AC
A longitudinal study of gait function and characteristics of gait disturbance in individuals with Alzheimer's disease.
Gait Posture. 2014 Apr;39(4):1022-7. Epub 2014 Jan 21 PubMed: 24491520PAPER Amtul Z, Nikolova S, Gao L, Keeley RJ, Bechberger JF, Fisher AL, Bartha R, Munoz DG, McDonald RJ, Naus CC, Wojtowicz JM, Hachinski V, Cechetto DF
Comorbid Aβ toxicity and stroke: hippocampal atrophy, pathology, and cognitive deficit.
Neurobiol Aging. 2014 Jul;35(7):1605-14. Epub 2014 Jan 8 PubMed: 24491422PAPER Barnes DE, Beiser AS, Lee A, Langa KM, Koyama A, Preis SR, Neuhaus J, McCammon RJ, Yaffe K, Seshadri S, Haan MN, Weir DR
Development and validation of a brief dementia screening indicator for primary care.
Alzheimers Dement. 2014 Feb 1; PubMed: 24491321PAPER O'Callaghan P, Noborn F, Sehlin D, Li JP, Lannfelt L, Lindahl U, Zhang X
Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
Amyloid. 2014 Jun;21(2):76-87. Epub 2014 Feb 3 PubMed: 24491019Current Filters
No filters selected